E-LIB Suche - Ergebnisse für: Wasamoto, Satoshi

1

Efficacy and Safety of First-line Pembrolizumab Plus Platin..:

Wasamoto, Satoshi ; Imai, Hisao ; Tsuda, Takeshi...
Internal Medicine. , 2024

Link: https://doi.org/10.2169/..

2

Using the neutrophil‐to‐lymphocyte ratio to predict the out..:

Imai, Hisao ; Wasamoto, Satoshi ; Tsuda, Takeshi...
Thoracic Cancer. 14 (2023) 25 - p. 2567-2578 , 2023

Link: https://doi.org/10.1111/..

3

Pretreatment glasgow prognostic score predicts survival amo..:

Wasamoto, Satoshi ; Imai, Hisao ; Tsuda, Takeshi...
Frontiers in Oncology. 12 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Real‐world data of atezolizumab plus carboplatin and etopos..:

Shiono, Ayako ; Imai, Hisao ; Wasamoto, Satoshi...
Cancer Medicine. 12 (2022) 1 - p. 73-83 , 2022

Link: https://doi.org/10.1002/..

5

Efficacy and safety of amrubicin monotherapy after atezoliz..:

Imai, Hisao ; Nagai, Yoshiaki ; Minemura, Hiroyuki...
Investigational New Drugs. 40 (2022) 5 - p. 1066-1079 , 2022

Link: https://doi.org/10.1007/..

6

Post‐progression survival after atezolizumab plus carboplat..:

Masubuchi, Ken ; Imai, Hisao ; Wasamoto, Satoshi...
Thoracic Cancer. 13 (2022) 19 - p. 2776-2785 , 2022

Link: https://doi.org/10.1111/..

7

Predictive value of post‐treatment C‐reactive protein‐to‐al..:

Araki, Taisuke ; Tateishi, Kazunari ; Komatsu, Masamichi...
Thoracic Cancer. 13 (2022) 14 - p. 2031-2040 , 2022

Link: https://doi.org/10.1111/..

8

Wheezing and Weightlifting:

Yanagisawa, Satoru ; Wasamoto, Satoshi ; Takechi, Hiroki.
Internal Medicine. 61 (2022) 6 - p. 931-932 , 2022

Link: https://doi.org/10.2169/..

9

Beneficial impact of weight loss on respiratory function in..:

Sekine, Akimasa ; Wasamoto, Satoshi ; Hagiwara, Eri...
Respiratory Investigation. 59 (2021) 2 - p. 247-251 , 2021

Link: https://doi.org/10.1016/..

10

Efficacy and safety ofS‐1 monotherapy in previously treated..:

Imai, Hisao ; Minemura, Hiroyuki ; Kishikawa, Takayuki...
Thoracic Cancer. 11 (2020) 10 - p. 2867-2876 , 2020

Link: https://doi.org/10.1111/..

11

Efficacy and safety of immune checkpoint inhibitor monother..:

Yamaguchi, Ou ; Imai, Hisao ; Minemura, Hiroyuki...
Cancer Chemotherapy and Pharmacology. 85 (2020) 4 - p. 761-771 , 2020

Link: https://doi.org/10.1007/..

12

Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-posi..:

Yanagisawa, Satoru ; Wasamoto, Satoshi ; Endoh, Hideki
Internal Medicine. 58 (2019) 23 - p. 3487-3488 , 2019

Link: https://doi.org/10.2169/..

13

Efficacy and safety of first-line pembrolizumab monotherapy..:

Imai, Hisao ; Wasamoto, Satoshi ; Yamaguchi, Ou...
Journal of Cancer Research and Clinical Oncology. 146 (2019) 2 - p. 457-466 , 2019

Link: https://doi.org/10.1007/..

14

Using the neutrophil‐to‐lymphocyte ratio to predict the out..:

Imai, Hisao ; Wasamoto, Satoshi ; Tsuda, Takeshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481141/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Post‐progression survival after atezolizumab plus carboplat..:

Masubuchi, Ken ; Imai, Hisao ; Wasamoto, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527159/. , 2022

Link: http://www.ncbi.nlm.nih...